France · Question · Question écrite
9282
Question 9282 — pharmacy and medications
Introduced
5 August 2025
Last action
—
Status
répondue
Sponsors
—
Subjects
Discovery layer
Source updated
1 September 2026
Summary
Mr. Julien Guibert draws the attention of the Minister of Agriculture and Food Sovereignty to the worrying development of certain practices observed in the veterinary sector and to their economic, health and environmental consequences. In rural areas like Nièvre, local veterinarians provide an essential service to breeders. Their movements in breeding and the care they provide are expensive and unprofitable. To maintain the economic viability of their practices, these practitioners integrate the sale of drugs into their economic model, in compliance with ethics and after examining the animals. This source of income is often essential to compensate for the low margins generated by field activities. However, a model inspired by the Belgian “responsible veterinarian” is developing in France: practitioners or commercial structures multiply prescriptions for vaccines, antiparasitics or antibiotics without traveling and without rigorous clinical monitoring, in conjunction with pharmacies. This system, based on very important and poorly controlled prescriptions, upsets the balance between field veterinarians and these new stakeholders. It increases unfair competition: practices that travel to treat and ensure the health of farms are penalized, while structures which simply distribute medicines remotely maximize their margins. Ultimately, this economic imbalance risks weakening the veterinary network in the countryside and harming breeders, deprived of individualized advice. This mercantile drift also raises health and environmental questions: an increase in prescriptions without adequate examination encourages treatment errors, the emergence of antimicrobial resistance and the dispersion of drug residues in soil and water. However, the root of the problem remains the breakdown in equity between the economic models of local veterinarians and those of “remote” prescribers. In this context, he asks her if she intends to take regulatory measures aimed at rebalancing competition between veterinarians. locals and these new actors. He would like to know if the supervision of the sale of medicines could be strengthened by making prescriptions subject to a compulsory clinical examination and by limiting the duration or volume of treatments delivered. He questions him on the possibility of increasing the controls carried out by the National Veterinary Medicines Agency and on the measures envisaged to slow down the implementation of a model of massive prescriptions without travel, in order to preserve animal health, the economic balance of local practices, food sovereignty and the preservation of the environment.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE9282
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE9282